TNYA — Tenaya Therapeutics, Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1858848 ·
Last close
$0.32
Market Cap
$73.58M
52W High
$1.46
52W Low
$0.30
ADV30
3,424,272
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 1,697,000 — -18,817,000 -18,938,000 76,681,000 66,797,000 22,164,000
Jun 2026 1,110,000 — -20,899,000 -43,393,000 93,540,000 78,085,000 24,131,000
Mar 2026 225,000 — -20,065,000 -19,272,000 135,070,000 80,887,000 28,881,000
Dec 2025 0 — -20,775,000 -20,175,000 146,921,000 100,547,000 23,656,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-54,410,000
Investing CF
$-211,000
Financing CF
$65,106,000
CapEx
$-263,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.49
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-686,611,000
Inventory
—
Receivables
$573,000
ST Investments
$0
EBIT TTM
$-80,556,000
Pretax Income TTM
$-101,778,000
Interest Exp TTM
—
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,335,000
EBITDA
$-75,524,000
Free Cash Flow
$-32,600,500
Enterprise Value
$8,806,681
Total Cash
$78,085,000
Total Debt
$3,949,000
Shares Out
227,928,240
Trailing EPS
$-0.48
Book Value
$0.57
ROE
-121.9%
ROA
-47.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -93,331,000 -90,597,000 146,921,000 23,656,000 123,265,000 -68,264,000
Dec 2024 0 -115,948,000 -111,129,000 119,940,000 27,086,000 92,854,000 -90,501,000
Dec 2023 0 -131,193,000 -124,084,000 170,515,000 31,091,000 139,424,000 -102,072,000
Dec 2022 0 -125,621,000 -123,665,000 278,945,000 35,569,000 243,376,000 -104,424,000

TTM Snapshot

Revenues TTM
$2,567,000
NetIncome TTM
$-103,115,000
OpCashFlow TTM
—
Assets (Latest)
$93,540,000
Forward EPS
$-0.38

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $0.50 · spot: $0.31 · call volume: 209 · put volume: 40
Expected Move to 2026-12-18: ±$0.20 (65.15%) — implied range $0.11 – $0.51 · ATM straddle on $0.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
CHRS Coherus Oncology, Inc. $73.95M $0.48 —
CLLS Cellectis S.A. $77.08M $1.06 —
AVXL ANAVEX LIFE SCIENCES CORP. $68.60M $0.74 —
ATRA Atara Biotherapeutics, Inc. $66.22M $6.50 —
CRDF Cardiff Oncology, Inc. $65.85M $0.85 —

News headlines (Yahoo Finance, 1h cache)

Tenaya Therapeutics, Inc. (TNYA) Reports Q3 Loss, Beats Revenue Estimates
2026-11-04 23:45 · Yahoo
Tenaya Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-04 21:05 · Yahoo
Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
2026-09-14 12:30 · Yahoo
Treasury yields rise as investors raise bets on Fed rate hike: AlphaCheck
2026-09-10 13:56 · Yahoo
Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
2026-09-03 20:30 · Yahoo
Tenaya Therapeutics Eyes Q4 Updates for Cardiac Gene Therapies, TN-301
2026-08-18 08:01 · Yahoo
Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-08-05 20:05 · Yahoo
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
2026-07-15 01:00 · Yahoo
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
2026-06-29 12:30 · Yahoo
Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026
2026-05-29 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.